BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33262303)

  • 1. Metaanalysis Reveals Genetic Correlates of Osteoporosis Pathogenesis.
    Hasan LK; Aljabban J; Rohr M; Mukhtar M; Adapa N; Salim R; Aljabban N; Syed S; Syed S; Panahiazar M; Hadley D; Jarjour W
    J Rheumatol; 2021 Jun; 48(6):940-945. PubMed ID: 33262303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-218 competes with differentiation media in the induction of osteogenic differentiation of mesenchymal stem cell by regulating β-catenin inhibitors.
    Karimi Z; Seyedjafari E; Khojasteh A; Hashemi SM; Kazemi B; Mohammadi-Yeganeh S
    Mol Biol Rep; 2020 Nov; 47(11):8451-8463. PubMed ID: 33051753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin promotes osteogenic differentiation of mesenchymal stem cells in the rat model of osteoporosis by the Wnt/β-catenin signal.
    Wang BX; Li KP; Yu T; Feng HY
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10161-10168. PubMed ID: 31799688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress of Wnt Signaling Pathway in Osteoporosis.
    Gao Y; Chen N; Fu Z; Zhang Q
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in Wnt/β-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study.
    Amorim T; Durães C; Machado JC; Metsios GS; Wyon M; Maia J; Flouris AD; Marques F; Nogueira L; Adubeiro N; Koutedakis Y
    Osteoporos Int; 2018 Oct; 29(10):2261-2274. PubMed ID: 29978256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-124-3p promotes BMSC osteogenesis via suppressing the GSK-3β/β-catenin signaling pathway in diabetic osteoporosis rats.
    Li Z; Zhao H; Chu S; Liu X; Qu X; Li J; Liu D; Li H
    In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):723-734. PubMed ID: 33085064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
    Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
    Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Inhibition of MicroRNA-139-5p Promoted Osteoporosis of Bone Marrow-Derived Mesenchymal Stem Cells by Targeting Wnt/Beta-Catenin Signaling Pathway by NOTCH1.
    Feng Y; Wan P; Yin L; Lou X
    J Microbiol Biotechnol; 2020 Mar; 30(3):448-458. PubMed ID: 31752063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNAp21 promotes osteogenic differentiation of mesenchymal stem cells in the rat model of osteoporosis by the Wnt/β-catenin signaling pathway.
    Yang K; Tian N; Liu H; Tao XZ; Wang MX; Huang W
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4303-4309. PubMed ID: 31173302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcriptional profile of mesenchymal stem cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors.
    Benisch P; Schilling T; Klein-Hitpass L; Frey SP; Seefried L; Raaijmakers N; Krug M; Regensburger M; Zeck S; Schinke T; Amling M; Ebert R; Jakob F
    PLoS One; 2012; 7(9):e45142. PubMed ID: 23028809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HOTAIR inhibited osteogenic differentiation of BMSCs by regulating Wnt/β-catenin pathway.
    Shen JJ; Zhang CH; Chen ZW; Wang ZX; Yang DC; Zhang FL; Feng KH
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7232-7246. PubMed ID: 31539110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of DNA methyltransferase-3a ameliorates the osteogenic differentiation ability of adipose-derived stem cells in diabetic osteoporosis via Wnt/β-catenin signaling pathway.
    Zhang M; Gao Y; Li Q; Cao H; Yang J; Cai X; Xiao J
    Stem Cell Res Ther; 2022 Aug; 13(1):397. PubMed ID: 35927735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of LECT2 promotes osteogenic differentiation of MSCs via activating Wnt/β-catenin pathway.
    Xu Z; He J; Zhou X; Zhang Y; Huang Y; Xu N; Yang H
    Biomed Pharmacother; 2020 Oct; 130():110593. PubMed ID: 32763823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibit Osteoporosis via MicroRNA-27a-Induced Inhibition of DKK2-Mediated Wnt/β-Catenin Pathway.
    Wang Y; Zhou X; Wang D
    Inflammation; 2022 Apr; 45(2):780-799. PubMed ID: 34676493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-protein-coupled receptor 124 promotes osteogenic differentiation of BMSCs through the Wnt/β-catenin pathway.
    Ma J; Chen P; Wang R
    In Vitro Cell Dev Biol Anim; 2022 Aug; 58(7):529-538. PubMed ID: 35916978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA metastasis-associated lung adenocarcinoma transcript-1 promotes osteogenic differentiation of bone marrow stem cells and inhibits osteoclastic differentiation of Mø in osteoporosis via the miR-124-3p/IGF2BP1/Wnt/β-catenin axis.
    Li X
    J Tissue Eng Regen Med; 2022 Mar; 16(3):311-329. PubMed ID: 34962086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neohesperidin promotes the osteogenic differentiation of bone mesenchymal stem cells by activating the Wnt/β-catenin signaling pathway.
    Chang YW; Zhu WJ; Gu W; Sun J; Li ZQ; Wei XE
    J Orthop Surg Res; 2021 May; 16(1):334. PubMed ID: 34020675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders.
    García-Ibarbia C; Delgado-Calle J; Casafont I; Velasco J; Arozamena J; Pérez-Núñez MI; Alonso MA; Berciano MT; Ortiz F; Pérez-Castrillón JL; Fernández AF; Fraga MF; Zarrabeitia MT; Riancho JA
    Gene; 2013 Dec; 532(2):165-72. PubMed ID: 24096177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA DANCR and miR-320a suppressed osteogenic differentiation in osteoporosis by directly inhibiting the Wnt/β-catenin signaling pathway.
    Wang CG; Hu YH; Su SL; Zhong D
    Exp Mol Med; 2020 Aug; 52(8):1310-1325. PubMed ID: 32778797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology identifies fisetin as a treatment for osteoporosis that activates the Wnt/β-catenin signaling pathway in BMSCs.
    Liang G; Zhao J; Pan J; Yang Y; Dou Y; Yang W; Zeng L; Liu J
    J Orthop Surg Res; 2023 Apr; 18(1):312. PubMed ID: 37087476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.